Seidenberg Beth C's Form 4 filing
Latigo Biotherapeutics, Inc. (LTGO) · filed Aug 10, 2026
- Accession no.
- 0001184592-26-000005
- Filed
- Aug 10, 2026, 8:00 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 7 derivative transactions. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seidenberg Beth CCIK 0001184592 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | CConversionAcquired | +938,979 | – | – | 1,368,532 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionAcquired | +3,547,842 | – | – | 4,916,374 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionAcquired | +1,027,635 | – | – | 5,944,009 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionAcquired | +3,464,072 | – | – | 3,510,927 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionAcquired | +1,484,401 | – | – | 4,995,328 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionAcquired | +165,519 | – | – | 5,160,847 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionAcquired | +2,066,857 | – | – | 2,094,813 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | CConversionDisposed | −938,979 | – | – | 0 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionDisposed | −3,547,842 | – | – | 0 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionDisposed | −1,027,635 | – | – | 0 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionDisposed | −3,464,072 | – | – | 0 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionDisposed | −1,484,401 | – | – | 0 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionDisposed | −2,066,857 | – | – | 0 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionDisposed | −165,519 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.